RE: Short Term Stability18 Nov 2020 15:35
Useful post only1, thanks...
Not being a 'medico' at all, I look at this sector as being at the centre of fighting this pernicious virus - yes vaccines will / should come into their own soon but, for now, testing and therapy treatments are the 'front line', imv.
With NCYT we have the 'gold standard' in the former category quite clearly and awareness of its growing reputation can only accelerate in this climate to major advantage. As for the latter grouping, Synairgen, looks streets ahead in its field, too - just needs their phase 3 trial outcome to confirm what phase 2 revealed and SNG should be substantially re-rated in short order, too, imv.
Having spent a good bit of time researching both sectors, I reckon these two are the 'best in class' where they reside and I'm just sitting on my holdings in them as the best two 'bug fighters' I've found to date and thus warrant proper investment (ergo, not fussed about short term sp movements) as quality almost invariably outs in the end.
'Aggressive inactivity', I call it, until we have a better idea how much these two Cos are really worth eventually; don't post much on either bb but just my take for now, fwiw - sasa.